Besides stating, complcations occurring during pregnancy and delivery and after birth the q'uestionnaire gave the rhesus state of the mother and child and information on whether immunopropbiylaxis had been administered to Rh-negative women taking part in study.
the mother after delivery. In this way we confirmed that no Rh negative women had been overlooked. The women's serum was examined for rhesus antibodies at amniocentesis, about four weeks later, and at delivery. Women who delivered a live Rh positive baby were sent a letter asking them to have a final blood test taken, either at the hospital or at their general practitioner, a minimum of six months after delivery to ensure that the passively administered immunoglobulin had disappeared from their circulation. ' Amniocentesis was performed under real time ultrasound guidance with the full bladder technique, without anaesthesia, and under sterile conditions. Median gestational age (estimated from the biparietal diameter of the fetus) at amniocentesis was 16-5 (range 14-22) weeks. 
Discussion
To our knowledge, ours is the first prospective study of Rh negative women who had amniocentesis without being given anti-D IgG and who were followed up with antibody tests during pregnancy and after delivery. As we did not include control groups we compared our results with the incidence of spontaneous immunisation during pregnancy. The McMaster conference reported an immunisation incidence of I1-% on the basis of 30 155 first pregnancies checked six months after delivery.7 Multigravidas show a higher incidence than primigravidas-22% and 1-6% respectively-when screened three days after delivery with a sensitive autoanalyser and the two stage papain technique as in our study. 8 As 515 (79%) of the women in our study were multigravidas the incidence of spontaneous immunisation during pregnancy might be expected to be higher than 1-1%. The observed incidence of immunisation was 0-8% within three days after delivery and 1-4% (95% confidence limits 0-2% to 2-6%) six months after delivery. Amniocentesis thus did not seem to enhance the risk of rhesus immunisation. The wide confidence interval, however, means that we cannot exclude the possibility that amniocentesis exposes Rh negative women to a slightly higher risk of immunisation. On the other hand, at least three of the five women who developed anti-D antibodies during the study might have been presensitised by events in previous pregnancies ( '8 Finally, the safety of administering-anti-D IgG early in the second trimester has not been definitely assessed. It should also be remembered that anti-D IgG is still a. human product, and its -production and collection are not completely without hazards. '9 In Denmark, where it has not been c'onsidered necessary to administer antenatal, immunoprophylaxis to prevent rhes'us imnsation during pregnancy, we find it consistent to refrain from administering anti-D IgG at genetic amniocentesis.
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